The development of 3-dimensional implantable liver organoids

Liver disease kills more people in the UK than diabetes and road deaths combined, yet the only cure—a liver transplant—is unavailable to many patients who die waiting. This research aims to build a substitute: three-dimensional, implantable liver tissue grown from human cells in the lab. Current attempts produce only tiny fragments that lack key liver functions. The team has assembled specialists in cell biology, tissue engineering, and clinical medicine to overcome these limits and create tissue with clinically relevant function. If successful, this work could provide an alternative to transplantation for patients with end-stage cirrhosis or acute liver failure. Instead of lifelong immunosuppressive drugs—which raise risks of infection, cancer, and heart disease—patients might receive a lab-grown organoid that performs the liver’s essential tasks. This would reduce pressure on the donor organ waiting list and change the treatment landscape for a disease that is rising in the UK. The project is applied, not fundamental science: its goal is a practical medical device, not a discovery about basic biology.